Oxidative Burst, Phagocytosis and Expression of Adhesion Molecules

Cellular Diagnostics: Basic principles, methods and clinical applications of flow cytometry

Volumn , Issue , 2008, Pages 343-376

  Lun, Andreas ^a   Schulze, Ilka ^b   Roesler, Joachim ^c   Wahnd, Volker ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d Klinikum Uckermark   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882362525     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000209171     Document Type: Chapter

References (63)

1. Albelda SM, Smith CW, Ward PA: Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-512.
2. Winkelstein JA, Marino MC, Johnston RB, Jr., Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H: Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155-169.
3. Lun A, Roesler J, Renz H: Unusual late onset of X-linked chronic granulomatous disease in an adult woman after unsuspicious childhood. Clin Chem 2002;48:780-781.
4. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA: Phylogenetic perspectives in innate immunity. Science 1999;284:1313-1318.
5. Ezekowitz RA: Role of themannose-binding lectin in innate immunity. J Infect Dis 2003;187(suppl 2):S335-S339.
6. Domachowske JB, Malech HL: Phagocytes; in Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W (eds): Clinical Immunology - Principles and Practice. St Louis, Mosby, 1996, vol 1, pp 392-407.
7. Mitchel NR, Cotran RS: Acute and chronic inflammation; in Kumar V, Cotran RS, Robbins SL (eds): Basic Pathology. Philadelphia, Saunders, 1996, pp 33-59.
8. Hayashi F, Means TK, Luster AD: Toll-like receptors stimulate human neutrophil function. Blood 2003;102:2660- 2669.
9. Medzhitov R, Janeway CA, Jr.: Innate immune induction of the adaptive immune response. Cold Spring Harb Symp Quant Biol 1999;64:429-435.
10. Akashi-Takamura S, Miyake K: Toll-like receptors (TLRs) and immune disorders. J Infect Chemother 2006;12:233-240.
11. Schroder NW, Schumann RR: Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005;5:156-164.
12. Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X, Zhang X, Gao X, Zhu Y, He F: Association between mannosebinding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005;192:1355-1361.
13. Terai I, Kobayashi K, Matsushita M, Miyakawa H, Mafune N, Kikuta H: Relationship between gene polymorphisms of mannose-binding lectin (MBL) and two molecular forms of MBL. Eur J Immunol 2003;33:2755-2763.
14. Cedzynski M, Szemraj J, Swierzko AS, Bak-Romaniszyn L, Banasik M, Zeman K, Kilpatrick DC: Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 2004;136:304-311.
15. Dean MM, Minchinton RM, Heatley S, Eisen DP: Mannose binding lectin acute phase activity in patients with severe infection. J Clin Immunol 2005;25:346-352.
16. Takahashi K, Shi L, Gowda LD, Ezekowitz RA: Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection. Infect Immun 2005;73:8188-8193.
17. Neth O, Hann I, Turner MW, Klein NJ: Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001;358:614-618.
18. Ezekowitz RA: Mannose-binding lectin in prediction of susceptibility to infection. Lancet 2001;358:598-599.
19. Campbell JJ, Butcher EC: Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 2000;12:336-341.
20. Anderson DC, Springer TA: Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150.95 glycoproteins. Annu Rev Med 1987;38:175-194.
21. Polley MJ, Phillips ML, Wayner E, Nudelman E, Singhal AK, Hakomori S, Paulson JC: CD62 and endothelial cellleukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci USA 1991;88:6224-6228.
22. Phillips ML, Schwartz BR, Etzioni A, Bayer R, Ochs HD, Paulson JC, Harlan JM: Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J Clin Invest 1995;96:2898-2906.
23. Alon R, Aker M, Feigelson S, Sokolovsky-Eisenberg M, Staunton DE, Cinamon G, Grabovsky V, Shamri R, Etzioni A: A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood 2003;101:4437-4445.
24. Pasvolsky R, Feigelson SW, Kilic SS, Simon AJ, Tal-Lapidot G, Grabovsky V, Crittenden JR, Amariglio N, Safran M, Graybiel AM, Rechavi G, Ben Dor S, Etzioni A, Alon R: A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med 2007;204:1571-1582.
25. Kuijpers TW, van Lier RA, Hamann D, de Boer M, Thung LY, Weening RS, Verhoeven AJ, Roos D: Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta-2-integrins. J Clin Invest 1997;100:1725-1733.
26. Quie P, Mills EL, Roberts RL, Noya FJD: Disorders of the polymorphonuclear phagocytic system; in Stiehm ER (ed): Immunologic Disorders in infants and children. Philadephia, Saunders, 1996, pp 446-447.
27. Wild MK, Luhn K, Marquardt T, Vestweber D: Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs 2002;172:161-173.
28. Heyworth PG, Cross AR, Curnutte JT: Chronic granulomatous disease. Curr Opin Immunol 2003;15:578-584.
29. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM: Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000;79:170-200.
30. Gombart AF, Shiohara M, Kwok SH, Agematsu K, Komiyama A, Koeffler HP: Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-epsilon. Blood 2001;97:2561-2567.
31. Shiflett SL, Kaplan J, Ward DM: Chediak-Higashi syndrome: a rare disorder of lysosomes and lysosome related organelles. Pigment Cell Res 2002;15:251-257.
32. Akira S, Sato S: Toll-like receptors and their signaling mechanisms. Scand J Infect Dis 2003;35:555-562.
33. YumHK, Arcaroli J, Kupfner J, Shenkar R, Penninger JM, Sasaki T, Yang KY, Park JS, Abraham E: Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol 2001;167:6601-6608.
34. Strassheim D, Asehnoune K, Park JS, Kim JY, He Q, Richter D, Kuhn K, Mitra S, Abraham E: Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J Immunol 2004;172:5727-5733.
35. Yuo A, Kitagawa S, Suzuki I, Urabe A, Okabe T, Saito M, Takaku F: Tumor necrosis factor as an activator of human granulocytes. Potentiation of the metabolisms triggered by the Ca2+-mobilizing agonists. J Immunol 1989;142:1678-1684.
36. Becker R, Pfluger KH: Myeloperoxidase deficiency: an epidemiological study and flow-cytometric detection of other granular enzymes in myeloperoxidase-deficient subjects. Ann Hematol 1994;69:199-203.
37. Ward DM, Shiflett SL, Kaplan J: Chediak-Higashi syndrome: a clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med 2002;2:469-477.
38. Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, Ahlin A, Nemet K, Hossle JP, Bernatowska-Matuszkiewicz E, Middleton-Price H: Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996;87:1663-1681.
39. Allende LM, Hernandez M, Corell A, Garcia-Perez MA, Varela P, Moreno A, Caragol I, Garcia-Martin F, Guillen-Perales J, Olive T, Espanol T, Arnaiz-Villena A: A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/lymphocyte function-associated antigen-1 functional association in humans. Immunology 2000;99:440-450.
40. Abramson JS, Mills EL, Sawyer MK, Regelmann WR, Nelson JD, Quie PG: Recurrent infections and delayed separation of the umbilical cord in an infant with abnormal phagocytic cell locomotion and oxidative response during particle phagocytosis. J Pediatr 1981;99:887-894.
41. Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, Hirschberg CB, Tonetti M: Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation. Am J Med Genet 2002;110:131-135.
42. Stahl D, Hänsch GM: Granulozyten-Funktionspr?fung; in Thomas L (Hrsg): Labor und Diagnose. Frankfurt, TH-Books Verlagsgesellschaft, 1998, pp 804-811.
43. Sietses C, Wiezer MJ, Eijsbouts QA, van Leeuwen PA, Beelen RH, Meijer S, Cuesta MA: The influence of laparoscopic surgery on postoperative polymorphonuclear leukocyte function. Surg Endosc 2000;14:812-816.
44. Gu Y, Williams DA: RAC2 GTPase deficiency and myeloid cell dysfunction in human and mouse. J Pediatr Hematol Oncol 2002;24:791-794.
45. Dobmeyer TS, Raffel B, Dobmeyer JM, Findhammer S, Klein SA, Kabelitz D, Hoelzer D, Helm EB, Rossol R: Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur J Med Res 1995;1:9-15.
46. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A: Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-497.
47. Ducusin RJ, Uzuka Y, Satoh E, Otani M, Nishimura M, Tanabe S, Sarashina T: Effects of extracellular Ca2p on phagocytosis and intracellular Ca2p concentrations in polymorphonuclear leukocytes of postpartum dairy cows. Res Vet Sci 2003;75:27-32.
48. Wenisch C, Parschalk P, Graninger W: Effect of ciprofloxacin and other quinolones on granulocyte function assessed by flow cytometry. Drugs 1995;49(suppl 2):301-303.
49. Rothe G, Emmendorffer A, Oser A, Roesler J, Valet G: Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine 123. J Immunol Methods 1991;138:133-135.
50. Roesler J, Hecht M, Freihorst J, Lohmann-Matthes ML, Emmendorffer A: Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry. Eur J Pediatr 1991;150:161-165.
51. Emmendorffer A, Hecht M, Lohmann-Matthes ML, Roesler J: A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123. J Immunol Methods 1990;131:269-275.
52. Emmendorffer A, Nakamura M, Rothe G, Spiekermann K, Lohmann-Matthes ML, Roesler J: Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry 1994;18:147-155.
53. Rothe G, Kellermann W, Schaerer B, Valet G: Messung der phagosomalen Wasserstoffperoxidproduktion von Granulozyten und Monozyten mit Dihydrorhodamin 123; in Schmitz G, Rothe G (Hrsg): Durchflubzytometrie in der klinischen Zelldiagnostik. Stuttgart, Schattauer, 1994, pp 331-350.
54. Vowells SJ, Fleisher TA, Sekhsaria S, Alling DW, Maguire TE, Malech HL: Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 1996;128:104-107.
55. Frohlich D, Rothe G, Wittmann S, Schmitz G, Schmid P, Taeger K, Hobbhahn J: Nitrous oxide impairs the neutrophil oxidative response. Anesthesiology 1998;88:1281-1290.
56. Frohlich D, Rothe G, Schwall B, Schmitz G, Hobbhahn J, Taeger K: Thiopentone and propofol, but not methohexitone nor midazolam, inhibit neutrophil oxidative responses to the bacterial peptide FMLP. Eur J Anaesthesiol 1996;13:582-588.
57. Yuan L, Inoue S, Saito Y, Nakajima O: An evaluation of the effects of cytokines on intracellular oxidative production in normal neutrophils by flow cytometry. Exp Cell Res 1993;209:375-381.
58. Vanholder R, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E, Ringoir S: Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 1995;47:510-517.
59. Riecken B, Gutfleisch J, Schlesier M, Peter HH: Impaired granulocyte oxidative burst and decreased expression of leucocyte adhesion molecule-1 (LAM-1) in patients with Wegener's granulomatosis. Clin Exp Immunol 1994;96:43-47.
60. Williams DA, Tao W, Yang F, Kim C, Gu Y, Mansfield P, Levine JE, Petryniak B, Derrow CW, Harris C, Jia B, Zheng Y, Ambruso DR, Lowe JB, Atkinson SJ, Dinauer MC, Boxer L: Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 2000;96:1646-1654.
61. Gray GR, Stamatoyannopoulos G, Naiman SC, Kliman MR, Klebanoff SJ, Austin T, Yoshida A, Robinson GC: Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet 1973;ii:530-534.
62. Prince HE, Lape-Nixon M: Influence of specimen age and anticoagulant on flow cytometric evaluation of granulocyte oxidative burst generation. J Immunol Methods 1995;188:129-138.
63. Mauch L, Lun A, O'gorman MR, Harris JS, Schulze I, Zychlinsky A, Fuchs T, Oelschlagel U, Brenner S, Kutter D, Rosen-Wolff A, Roesler J: Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Clin Chem 2007;53:890-896.